Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Bronchiolitis Obliterans Syndrome

• Efficacy of Bee Venom Phonophoresis in Treating Chronic Sinusitis:
• A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host Disease
• A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD)
• Comparison Between Oral Gabapentin Versus Diclofenac Sodium in Post-operative Analgesia Laparoscopic Cholecystectomy
• A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
• A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
• Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis
• Comparison of Ganglion Impar Radiofrequency Ablation and Phenol Neurolysis Techniques for Chronic Coccydynia Treatment
• Gecacitinib for cGVHD: Safety and Efficacy in Patients After 2 Lines of Prior Therapy
• Impact of Dapagliflozin in Anemic Chronic Kidney Disease Patients
• A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or Refractory cGVHD
• Duloxetine As an Analgesic in Patients Without Central Sensitivity After Same Sitting Bilateral Total Knee Arthroplasty
• A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy
• Intracerebral Autologous Stem Cell Therapy for Chronic Stroke Patients
• The Use of Cyproheptadine in Pediatric Feeding Disorders
• Upfront Ruxolitinib for Chronic Graft-vs-host Disease
• Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
• EOIB for Laparoscopic Cholecystectomy
• A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
• A Clinical Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belumosudil in Chinese Adolescents With cGVHD Who Have Had an Inadequate Response to Glucocorticoids or Other Systemic Therapies
• A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
• A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
• Effect of Sevoflurane and Desflurane on Heme Oxygenase-1 Expression in Elective Cholecystectomy
• Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation
• Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression
• A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
• Intracerebral Transplantation of Autologous MSC Combined With Scaffold Product for Chronic Intracerebral Hemorrhage
• A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
• Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Axatilimab Monotherapy in Japanese Participants With Recurrent or Refractory Active Chronic Graft-Versus-Host Disease
• Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD
• A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chronic Graft Versus Host Disease (cGvHD)
• TDI01 Suspension in the Treatment of Chronic Graft-versus-host Disease (cGVHD))
• A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.
• Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease
• LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
• Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
• BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
• A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of AMG 592 in Healthy Japanese Participants
• A Study to Evaluate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AMG 592 in Healthy Participants